Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 14/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.36 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL650074 | 0.95 | C5AR1 (0.43) | C5AR1CETPCRHR1 | |
| SCHEMBL651407 | 0.94 | C5AR1 (0.42) | C5AR1CETPCRHR1 | |
| SCHEMBL5135486 | 0.93 | C5AR1 (0.42) | C5AR1CETPCALM1CAMKK2TLR7 | |
| SCHEMBL648023 | 0.92 | C5AR1 (0.54) | C5AR1 | |
| SCHEMBL649156 | 0.91 | C5AR1 (0.42) | C5AR1CALM1CAMKK2TLR7PPARG | |
| SCHEMBL648926 | 0.91 | C5AR1 (0.41) | C5AR1CETP | |
| SCHEMBL648123 | 0.90 | C5AR1 (0.42) | C5AR1CETPCRHR1PPARGPPARA | |
| SCHEMBL648419 | 0.90 | C5AR1 (0.46) | C5AR1CALM1CAMKK2TLR7 | |
| SCHEMBL653132 | 0.89 | C5AR1 (0.40) | C5AR1CETPCRHR1 | |
| SCHEMBL648225 | 0.88 | C5AR1 (0.59) | C5AR1CETPPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119665-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2012-02-21 | — | — | US | disclosed |
| US-8119665-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2012-02-21 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |
| US-7186734-B2 | Aryl imidazoles and related compounds as C5a receptor modulators | NEUROGEN CORPORATION (US) | 2007-03-06 | — | — | US | disclosed |